P eople with diabetes have a 15% lifetime risk of developing a foot ulcer and have an amputation rate of 6/1000 people with diabetes/year (1). Recent data has suggested that 80% of foot ulcers and/or amputations can be prevented by daily foot examinations by the patient, foot care and appropriate footwear (2). Unfortunately, foot infection continues to be a pervasive problem for people with diabetes living in Canada, where the risk of amputation is 12 to 15 times that of the general population, and amputation is the most common cause of nontraumatic limb loss (3). This morbidity is compounded by the fact that of people with diabetes, 30% require amputation of the remaining limb at three years and 50% at four years after the first amputation (4). The mortality rate of diabetic amputees is also increased, with a three-year survival rate of 50% (5).
and straightforward care plan for the management of the diabetic foot using a multidisciplinary approach. The objective of this undertaking was not to provide a detailed review of the literature, as has been undertaken by several authors (6, 7) , but rather to incorporate the current state of knowledge into a workable care plan. The care plan was organized as per the format in Figure 1 , with sections discussing assessment of the diabetic foot (Table 1) , general management based on the findings of that assessment (Table 2 ) and finally a description of empirical antibiotic therapy based on the severity of infection (Table 3) . Where possible, photographic examples have been provided to illustrate various teaching points.
Empirical antibiotic therapy for diabetic foot infections has recently been reviewed (8, 9) , and these guidelines have been incorporated into this care plan with only minor modifications ( Table 3) . The empirical antibiotic choice should be altered based on appropriate culture results, once obtained.
The present care plan has been further supplemented by management guidelines based on the Wagner Classification (Table 4) . Previous research has indicated that the use of protocols based on the Wagner Classification may be associated with higher rates of ulcer healing (10) .
This care plan was developed with the input of a multidisciplinary panel and is intended to function as a general guideline from which deviation can and should be made, based on the particular clinical problem at hand and the opinion of the health care team.
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Infection
• Ulcers without inflammatory changes should not be cultured (unless patient is on immunosuppressive treatment or severe ischemia is present and infection is suspected) • Technique: cleanse ulcer base vigorously with saline and obtain deep swab for aerobic (and anaerobic) culture; if abscess is present, aspirate and culture the fluid. Anaerobes are seldom present if ulcer is superficial and present for less than four to eight weeks • Microbiology from a swab approximates a tissue biopsy and is adequate to guide antibiotic treatment (11, 12) • Osteomyelitis is diagnosed if there is visible bone or if bone is detected with a sterile probe; it is unlikely if ulcer is less than four weeks in duration (13) • Serial x-rays should be performed to follow bone remodelling during treatment and to diagnose occult osteomyelitis • Perform bone scan with or without gallium or white blood cell scan, only if serial x-rays are negative and osteomyelitis is strongly suspected (14) • Assess infection severity (as per • Treatment durations as per complicated nonlimb-threatening infection • Intravenous cefriaxone 1 g every 24 h plus either IV metronidazole 500 mg every 12 h or IV clindamycin 600 mg every 8 h, or • IV cefotaxime 1g every 8 h, plus either IV metronidazole 500 mg every 12 h or IV clindamycin 600 mg every 8h
• Intravenous piperacillin/tazobactam 4.5 g every 8 h or 3.375 g every 6 h, or • Intravenous ceftazidime 1 to 2 g every 8 h plus IV clindamycin 600 mg every 8 h, or • Intravenous imipenem/cilastatin 500/500 mg every 6 h IV Intravenous. 
